Exencial Wealth Advisors, LLC Crispr Therapeutics Ag Transaction History

Exencial Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$70.09 - $111.29 $353,884 - $561,903	-5,049 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$110.2 - $156.64 $79,013 - $112,310	-717 Reduced 12.43%	5,049 $565,000
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $69,982 - $112,351	694 Added 13.68%	5,766 $933,000
Q1 2021 May 06, 2021	BUY	$110.72 - $210.04 $252,552 - $479,101	2,281 Added 81.73%	5,072 $618,000
Q4 2020 Feb 11, 2021	BUY	$79.67 - $173.23 $222,358 - $483,484	2,791 New	2,791 $427,000

549

56.3M

2.91M

2.47M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.2B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.